A wealth of data support a role for serotonin (5-HT) function in the mediation of satiety responses, that are impaired in patients with bulimia nervosa. Testmeal results are presented in which 26 bulimic patients and 17 normal controls were given in randomized, double-blind-fashion, placebo, and the 5-HT agents m-chlorophenylpiperazine (m-CPP, 0.5 mglkg p.o.) and L-tryptophan (L-TRP, 100 mglkg I. V.). Three and one-half hours after drug administration, subjects were allowed to eat and lib from a standardized testmeal of 3,500 calories, after which postprandial vomiting was not allowed. M-CPP, but not L-TRP, significantly decreased meal size in the combined group, the controls, and to a lesser extent, the bulimics (p � .06). Maximum m-CPP Serotonergic manipulations are known to result in marked changes in feeding behaviors, particularly sati ety responses (Blundell 1977 (Blundell , 1984 (Blundell , 1986 Blundell and Latham, 1978 , 1982 Latham and Blundell 1979; Samanin et al. 1982; Silverstone and Goodall 1986; Garattini et al., 1988 Garattini et al., , 1989 , which are dysfunctional in bulimic patients (Owen et al. 1985; Chiodo and Latimer 1986; Kissileff et al. 1986 ). Pharmacologic en hancement of 5-HT neurotransmission in animals and concentrations were inversely correlated to the number of calories consumed in the total group. Following m-CPP, there were significant decreases in carbohydrate, protein, and fat intake in the total group of subjects. There were also trends for decreased carbohydrate and protein intake in the bulimics following m-CPP. There were trends for both m-CPP and L-TRP to reduce fat intake in the controls. Differences in the effects between m-CPP and L-TRP are likely due to differential involvement of 5-HT receptor subtypes at presynaptic and postsynaptic sites. These studies in humans confirm reports in animals that m-CPP decreases food intake, including carbohydrates, protein, and fat in a mixed testmeal.
A wealth of data support a role for serotonin (5-HT) function in the mediation of satiety responses, that are impaired in patients with bulimia nervosa. Testmeal results are presented in which 26 bulimic patients and 17 normal controls were given in randomized, double-blind-fashion, placebo, and the 5-HT agents m-chlorophenylpiperazine (m-CPP, 0.5 mglkg p.o.) and L-tryptophan (L-TRP, 100 mglkg I. V.). Three and one-half hours after drug administration, subjects were allowed to eat and lib from a standardized testmeal of 3,500 calories, after which postprandial vomiting was not allowed. M-CPP, but not L-TRP, significantly decreased meal size in the combined group, the controls, and to a lesser extent, the bulimics (p � .06). Maximum m-CPP Serotonergic manipulations are known to result in marked changes in feeding behaviors, particularly sati ety responses (Blundell 1977 (Blundell , 1984 (Blundell , 1986 Blundell and Latham, 1978 , 1982 Latham and Blundell 1979; Samanin et al. 1982; Silverstone and Goodall 1986; Garattini et al., 1988 Garattini et al., , 1989 , which are dysfunctional in bulimic patients (Owen et al. 1985; Chiodo and Latimer 1986; Kissileff et al. 1986 ). Pharmacologic en hancement of 5-HT neurotransmission in animals and concentrations were inversely correlated to the number of calories consumed in the total group. Following m-CPP, there were significant decreases in carbohydrate, protein, and fat intake in the total group of subjects. There were also trends for decreased carbohydrate and protein intake in the bulimics following m-CPP. There were trends for both m-CPP and L-TRP to reduce fat intake in the controls. Differences in the effects between m-CPP and L-TRP are likely due to differential involvement of 5-HT receptor subtypes at presynaptic and postsynaptic sites. These studies in humans confirm reports in animals that m-CPP decreases food intake, including carbohydrates, protein, and fat in a mixed testmeal. [Neuropsychopharmacology 11:63-71, 1994J man generally leads to increased satiety (Blundell 1984 (Blundell , 1986 , with the exception of 5-HT IA receptor activation that induces feeding in animals in specific paradigms (Dourish et al. 1985 (Dourish et al. , 1986 (Dourish et al. , 1988 . Conversely, attenua tion of 5-HT neurotransmission by various methods leads to decreased satiety and increased food consump tion and weight gain (Blundell and Latham 1978 , 1982 Blundell 1984 Blundell , 1986 . The effects of 5-HT on feed ing are thought to be mediated centrally via the medial hypothalamus Leibo witz et al. 1988; Leibowitz 1990 ), although there is some evidence that peripheral mechanisms may play a part (Pollock and Rowland 1981; Davies et al. 1983; Fletcher and Burton 1984) .
Patients with bulimia nervosa have several distur bances which suggest dysregulation of 5-HT function, including affective dysregulation, anxiety, impulsivity, and addiction (Brewerton et al. 1986 (Brewerton et al. , 1989 (Brewerton et al. , 1990a (Brewerton et al. , 1990b (Brewerton et al. , 1992c Jimerson et al. 1990 ).
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Given these relationships, we studied the feeding responses in normal weight patients with bulimia ner vosa and with healthy controls following challenge with the 5-HT precursor L-tryptophan (L-TRP) and the 5-HT agonist m-chlorophenylpiperazine (m-CPP) as well as placebo (both IV solution and capsules). A more de tailed discussion of the neuroendocrine and neurophar macological aspects, including side-effect profile, of these drugs as challenge agents has been studied (Brewerton et al., 1988 (Brewerton et al., , 1990a (Brewerton et al., , 1990b (Brewerton et al., , 1992c Murphy et al., 1991) .
SUBJECTS AND METHODS
The demographic features of the normal weight bulimic patients and the age and weight-matched female nor mal controls have been described (Brewerton et al. 1992b ), but will be briefly reviewed and are in Table 1 . There was not complete overlap between the m-CPP and L-TRP patient and control groups. All subjects were studied after at least four weeks off all medications, in cluding birth control pills. At the time of admission, all patients met DSM-III criteria (American Psychiatric Association, 1980) for bulimia; retrospectively, all pa tients were also found to meet DSM-III -R criteria (Amer ican Psychiatric Association 1987) for bulimia nervosa. None of the patients with bulimia met present or past DSM-III criteria for anorexia nervosa. Normal controls were selected on the basis of an absence of present or past major psychiatric illness as determined by the SADS-L (Spitzer and Endicott 1975) . There was no signifIcant difference in the weights of patients as com pared to controls (Table 1 ). All subjects were in good general health, not pregnant, and free of signifIcant medical illness on the basis of a thorough medical evalu ation including a physical examination, EKG, and ap propriate laboratory tests. In addition, controls were eliminated on the basis of a lifetime family history of any psychiatric disorder or obesity in a hrst degree rel ative. Each subject received an oral and written expla nation of the purposes, procedures, and potential haz ards of the project, and then gave informed consent.
All subjects were studied at the National Institute NEUROPSYCHOPHARMACOLOGY 1994-VOL. 11, NO.1
of Mental Health Clinical Center Eating Disorders Uni t after overnight bedrest and a 14 hour fast (except for water). In addition, 20 of the 26 bulimic subjects were inpatients at the time of the study, and had been absti nent from binging and vomiting for at least four weeks. Inpatients were treated on a highly structured, locked, inpatient unit with supervised meals and bathroom use. The daily caloric intake for all inpatients was prescribed and consisted of approximately 30 kcal/kg. All meals were prepared and checked by experienced dieticians for an appropriate balance of macronutrients, minerals, and vitamins. Patients were not allowed to exercise and were checked periodically by nursing staff to prevent excessive activity. All subjects also observed limited ac tivity levels and a low monoamine, alcohol free, low caffeine diet for at least 72 hours prior to the study. Sub jects who smoked were not allowed to do so on the days of the study. A 20 gauge intravenous catheter attached to a heparinized double stopcock was inserted by 9:00
A.M. on each of the procedure days. Double-blind ad ministration of m-CPP (0.5 mg/kg p.o.), L-TRP (100 mg/kg IV), or placebo was performed on separate days in random order of at least 48 hours apart. Each subject had an infusion of saline, or L-TRP, and the same num ber of capsules (placebo or m-CPP), except for six pa tients with indwelling venous lines who received only capsules on each day of two days (placebo or m-CPP). Plasma levels of m-CPP and L-TRP were measured by high pressure liquid chromatography (Miller and De vane 1986; Larsson et al. 1988 ). The Hamilton Depression Scale (HAMD) (Hamil ton 1960) was administered by one of the authors (IDB), and subjects completed the Beck Depression Inventory (BOI) (Beck 1961) on the morning of each study day. Subjects completed a side-effects check list throughout the procedure.
All subjects were given a standardized testmeal consisting of 3,500 calories, including 50% carbohy drates, 30% fat, and 20% protein, presented between three and a half hours and four hours post drug ad ministration. Subjects were instructed "to eat as much or as little as desired" in "as long or as short a period of time as desired." No vomiting was allowed. Outcome measures included meal size, duration, and macronu- Data are given as mean ± SD.
trient content (i.e., protein, carbohydrate, and fat). Mac ronutrients were calculated as both absolute amount in grams as well as percentage of total intake.
Data Analysis
Before analysis, all data were tested for normal distri bution and homogeneity of variance using the Statisti- cal Analysis System (SAS) Proc Unvariate. All data were parametric and were analyzed across groups using the unpaired t-test, and were analyzed within groups using the paired t-test. lyzed as such. Different sample sizes and incomplete overlap among subjects from drug to drug also indi cated separate analyses. This strategy has been used in reporting neuroendocrine results (Brewerton et a1. 1992c ). In addition, the outpatient bulimics were com bined with the inpatient bulimics because there were no signifIcant differences in any of the testmeal pa rameters between these two groups, and these patients served to increase the power of the statistics for treat ment and diagnosis effects. 
M-CPP versus Placebo
Testmeal duration was not signifIcantly different be tween m-CPP and placebo in the bulimics (m-CPP: 24.5 ± 11.7 min), the controls (m-CPP: 1B.1 ± 6.3 min), or the total group. In the total group of subjects, meal size (kcal) was signifIcantly reduced following m-CPP compared to placebo (n = 41, p< .02). In addition, meal (Figure 1 ). In the total group, m-CPP reduced the carbohydrate (p� .002, paired t-test), protein (p � .01), and fat intake (p � .02) in comparison to placebo (Figure 2) . Maximum m-CPP concentrations were significantly correlated with the total number of calories consumed (r = -0.33, p< .03) (Figure 3 ) and fat intake (r = -0.33, P = .033). A trend was noted for a significant correlation with car bohydrate intake as well (r = -0.27, P = .08).
There was a trend for bulimics to eat less carbohy drate (gms) after m-CPP than placebo (p < .1). There was also a trend for bulimics to eat less protein (in both absolute gms and % total intake) after m-CPP than placebo (p � .1), and there was a trend for controls to eat less fat (gms) after m-CPP (p < .1).
There were no significant correlations between maximum m-CPP concentrations and any of the test meal measures in the patients alone. However, in the controls, there was a trend for maximum m-CPP con centrations to be inversely correlated with the total number of calories eaten (n = 16, r = -0.45, P < .07) (Figure 3) , as well as the number of grams of protein (r = -0.44, P < .09) and fat consumed (r = -0.45, P < .08). 
L-TRP versus Placebo
There were no signifIcant differences in testmeal dura tion or size in the bulimics, the controls (Figure 4) or the total group. There were no significant diff erences in macronutrient selection in the total group of subjects. However, there was a trend for bulimics to eat less pro tein (% total cal) (p � .09) and for controls to eat less fat (gms) after L-TRP (p � .1) ( Figure 5 ). In comparison �o pla�ebo, there was a significant difference in change m fat mtake (gms) after L-TRP between bulimics and controls (p � .05), (i.e., overall, bulimics ate more fat [4.5 ± 16.8 gms] and controls at less [-3.9 ± 8.4 gms]). There were no significant correlations between maxi mum L-TRP concentrations and any of the testmeal measures in the patients, the controls, or the combined groups. There was a trend for maximum L-TRP con centrations to be correlated with fat intake in the pa tients alone (n = 23, r = 0.36, P = .088).
Placebo
Testmeal duration was significantly longer in the bu limics (n = 26,24.3 ± 9.2 minutes) as compared to the controls(n = 17,17. Figures I, 4 ). There was a trend for bu limics to eat signifIcantly less fat (23.7 ± 12.9 gms) than controls (31.0 ± 13.3 gms, p � .1) (Figure 4 ). There were no other signifIcant differences in macronutrient content between bulimics and controls on the placebo study day.
Depression Ratings
No signifIcant or near signifIcant correlations were found between any of the testmeal measures and HAMD and BDI scores.
Side Effects
As previously reported (Brewerton et al. 1992c) , mild nausea was the most common side effect for both agents. Maximum nausea ratings were signifIcantly higher following both agents in comparison to placebo, but there were no signifIcant differences between m-CPP and L-TRP. In addition, maximum ratings were not correlated to any of the testmeal measures.
DISCUSSION
M-CPP signifIcantly decreased testmeal size in the to tal group of volunteers (p � .002) and the healthy con trols alone (p < .05), and there was a trend for this effect in the bulimics alone (p < .06). This is compatible with reports in animals that m-CPP and other serotonergic agents decrease food intake (Samanin et al. 1982; Ken nett et al. 1987 Ken nett et al. , 1990 Curzon 1988a, 1988b; Aulakl et al. 1989) . Recent evidence indicates that m-CPP's effects on feeding are specifIcally mediated via 5-HTlC receptors Curzon 1988a, 1988b; Kennett et al. 1990 Kennett et al. , 1991 . The fInding of a signifIcant inverse correlation between m-CPP levels and total calories consumed is compatible with this hypothesis. In the total group of subjects, m-CPP induced decreases in food intake were nonspecifIc in that all macronu trients were suppressed to signifIcant degrees; however, the strongest case could be made for its effect on carbo hydrates, because this was the most robust fInding. Following the L-TRP challenge, bulimic patients ate slightly more, and controls ate slightly less after L-TRP, although these were not statistically signifIcant differ ences. Nor were there differences in the total group. The lack of signifIcant effect by intravenous L-TRP is similar to studies of oral L-TRP in humans in which few effects Wurtman 1981a, 1981b; Silver stone and Goodall 1986) or no effects were observed (Hrboticky et al. 1985; Krahn and Mitchell 1985; Russ et al. 1991) . These data add to considerable doubt about the extent to which L-TRP induced increases in 5-HT turnover actually cause enhanced 5-HT neurotransmis sion (Trulson 1985 ). Yet, L-TRP signifIcantly enhanced NEUROPSYCHOPHARMACOLOGY 1994-VOL. 11, NO.1 prolactin and cortisol secretion in these same patients, probably as a result of enhanced 5-HT function (Brewer ton et al. 1992c) .
Following placebo, bulimics ate fewer calories com pared to controls, although this was a nonsignifIcant difference and was probably a result of restrained eat ing in the bulimic subjects, given the vomiting re striction.
The effects of the 5-HT agents on the macro nutrient content of the testmeal differed somewhat by diagno sis. There was at least a trend for both m-CPP and L-TRP to reduce the percentage of protein ingested in the bu limics, but not the controls. M-CPP also reduced the grams of protein ingested in the bulimics, but not the grams of protein ingested in the controls. The case for a role of 5-HT in the direct regulation of protein intake is controversial and weak, and most of his work has been done in animals (Anderson 1979; Curtis-Prior 1983; Shor-Posner et al. 1986; Fernstrom 1987; Peters and Harper 1987) , so these data are provocative.
There is a much stronger case for a role for 5-HT in the regulation of carbohydrate intake (Fernstrom 1987) . Our fInding of a lack of effect of L-TRP on carbo hydrate intake in normal controls is contrary to studies in some (Latham and Blundell 1979; Gibbons et al. 1981 ), but not all animal studies (Peters et al. 1984) . However, following m-CPP, carbohydrate intake was decreased in the total group of subjects and the bulimic patients. Furthermore, there was a trend for a signifIcant inverse correlation between maximum m-CPP concen trations and carbohydrate intake in the total group of subjects. Other serotonergic agents, such as fenflura mine (Wurtman and Wurtman 1977; Burton et al. 1981; Li and Anderson 1984; Kim and Wurtrnan 1988a) , fluox etine (Wurtrnan and Wurtrnan 1977; Kim and Wurtrnan 1988b) , the 5-HT reuptake inhibitor. CGSI0686B (Kim and Wurtman 1988b) , as well as the postsynaptic agonist MK-212 (Wurtman and Wurtman 1979) , have all been shown to suppress carbohydrate ingestion in animals. There are no other studies in humans of m-CPP on food intake, but oral administration of L-TRP (Wurt man and Wurtrnan 1981a and Wurtrnan , 1981b Silverstone and Good all 1986) and fenfluramine (Wurtman and Wurtman 1977 , 1981a , 1981b Rogers et al. 1979; Hill and Blun dell, 1990) have been reported to decrease carbohydrate intake in man.
M-CPP also reduced the amount of fat intake in the total group and both agents reduced the grams of fat intake in the controls, but not the bulimics alone. In addition, fat intake was signifIcantly and inversely cor related with maximum m-CPP concentrations in the to tal group of subjects. There was also a signifIcant differ ence in change in fat intake (gms) after L-TRP between bulimics and controls (bulimics ate more fat and con trols ate less). Bulimic subjects ate fewer grams of fat than controls in this setting, which is compatible with clinical observations that bulimics and other restrained eaters avoid fat consumption. These results suggest that 5-HT may also play a role in modulating fat intake, per haps via its effects on the opiate system (Marks-Kaug man 1982; Shor-Posner et al. 1985; Leibowitz and Shor-Posner 1986; Brewerton et al. 1992b) .
Neither m-CPP, nor L-TRP produced signifIcant diff erences in testmeal duration in the bulimics, the con trols, or the total group. This has been demonstrated in animal studies to increase following enhancement of 5-HT function (Leibowitz et al. 1988) . Meal duration may be a less sensitive measure of 5-HT's effects on human feeding, which is more complex and multi-de termined. Not surprisingly, bulimics took signifIcantly more time to eat than the controls, regardless of the drug. Patients knew that they were subject to possible observation during eating and that they would not be able to purge following the testmeal; this situation may have increased food-related anxiety and avoidance be havior (Katzman and Wolchik 1984; Johnson et al. 1986; Davis et al. 1988) . The effects of the artifIcial nature of this eating paradigm on our results must be ac knowledged.
Administration of the two agents may be impor tant in interpreting our results. Although all agents were ad ministered at the same time (10 A.M.), the plasma lev els of the intravenously administered L-TRP peaked ear lier than the orally administered m-CPP. L-TRP may therefore have had a more rapid onset of action and a longer interval until the testmeal was presented than m-CPP may have had. However, L-TRP still has to be metabolized to 5-HT, enter the vesicles and be released, whereas m-CPP has a direct action on receptor sites. On the other hand, peak neuroendocrine responses to IV L-TRP occurred approximately one and a half hours earlier than the peak neuroendocrine responses to oral m-CPP (Brewerton et al. 1992c ). Other differences be tween m-CPP and L-TRP that could possibly explain diversity in feeding responses include presynaptic versus postsynaptic mechanisms, the subtype(s) of 5-HT receptor, the anatomic loci of action, comparative drug dose, and amount of pre study fasting. It is im possible to determine the degree to which nausea con tributed to the suppression of food intake. The effects of enhanced 5-HT function on other neurotransmitters (e.g., norepinephrine, acetylcholine, and peptides), such as the opiates (Brewerton et al. 1992b ) and CCK-8 (Brewerton et al. 1992a; Lydiard RB et al. 1993) , may also be important in understanding these results. Nevertheless, the observation that bulimics and con trols demonstrated some diversity in their responses to both serotonergic agents is consistent with a seroto nin dysregulation hypothesis of bulimia nervosa (Brewerton et al. 1986 (Brewerton et al. , 1989 (Brewerton et al. , 1991a (Brewerton et al. , 1991b (Brewerton et al. , 1992 Brewer ton, in press; Jansen et al. 1989; Goldbloom and Garfinkel, 1990; Jimerson et al. 1990; Liebowitz, 1990) .
In summary, this study determined that the sero tonin receptor agonist m-CPP produced a signifIcant Testmeal Responses to m-CPP and L-TRP 69 decrease in calorie intake in volunteers consuming a standardized test meal. Meal size was inversely corre lated with peak m-CPP drug levels, and the drug effects were not signifIcantly different for bulimic patients and for controls. Decreased food intake following m-CPP was relatively nonselective across macronutrients; the decrease in percentage was not signifIcantly different for protein or fat, although the most robust decrease was for carbohydrates.
